Hubei Biocause Heilen Pharmaceutical (301211) Key Financial Indicators

11.88
+0.27+2.33%

Noon Break Mar 27 11:30 CST

4.96BMarket Cap130.55P/E (TTM)

301211 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hubei Biocause Heilen Pharmaceutical shows that the company's current ratio is 13.95, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

301211 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the quick ratio is 13.00, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

301211 Return on Equity (ROE)

Want to learn more about the financial health of Hubei Biocause Heilen Pharmaceutical? The latest ROE figure is 0.92%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

301211 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the total asset return on investment (ROA) is 0.86%.

Currency: CNY

Cumulative Quarterly

301211 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hubei Biocause Heilen Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 20.53%.

Currency: CNY

Cumulative Quarterly

301211 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hubei Biocause Heilen Pharmaceutical, the net profit margin is 6.56%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.